Biogen Inc.

SNSE:BIIBCL 주식 보고서

시가총액: CL$22.7t

Biogen 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?


최근 내부자 거래

SNSE:BIIBCL 회사 또는 개인의 최근 내부자 거래
날짜가치이름엔티티역할공유최대 가격
02 Apr 24SellCL$19,350,572Priya SinghalIndividual93CL$208,070.67
22 Feb 24SellCL$56,743,314Priya SinghalIndividual262CL$216,577.53
15 Feb 24BuyCL$97,805,918Eric RowinskyIndividual455CL$214,958.06

내부자 거래량

내부자 구매: 내부자가 지난 3개월 동안 판매한 것보다 더 많은 주식을 구입했는지 판단하기에는 데이터가 부족합니다.


소유권 분석

BIIBCL 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
주 또는 정부140,3680.0963%
개인 내부자349,2210.24%
일반 대중13,678,8579.39%
교육기관131,550,89490.3%

주식의 희석: 지난 해 주주들은 의미 있게 희석되지 않았습니다.


최대 주주

상위 25 주주가 회사의 65.08%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
11.4%
The Vanguard Group, Inc.
16,678,507CL$2.6t0.47%0.04%
11.2%
PRIMECAP Management Company
16,315,079CL$2.5t-0.14%1.83%
10.5%
BlackRock, Inc.
15,347,041CL$2.4t5.56%0.04%
5.04%
State Street Global Advisors, Inc.
7,344,960CL$1.1t3.51%0.04%
4.23%
T. Rowe Price Group, Inc.
6,168,832CL$960.5b-19.8%0.08%
3.52%
Wellington Management Group LLP
5,131,193CL$798.9b-0.68%0.12%
2.48%
Geode Capital Management, LLC
3,613,020CL$562.5b1.32%0.04%
2.42%
JP Morgan Asset Management
3,524,314CL$548.7b6.09%0.06%
1.43%
Norges Bank Investment Management
2,078,745CL$323.6b0%0.03%
1.2%
Beutel Goodman & Company Ltd.
1,744,154CL$271.6b-0.19%1.21%
1.14%
UBS Asset Management AG
1,656,544CL$257.9b4.43%0.03%
1.04%
Legal & General Investment Management Limited
1,511,506CL$235.3b-2.41%0.04%
0.97%
Invesco Capital Management LLC
1,413,892CL$220.1b29.8%0.08%
0.93%
Northern Trust Global Investments
1,353,135CL$210.7b-5.1%0.03%
0.91%
Morgan Stanley, Investment Banking and Brokerage Investments
1,323,321CL$206.0b33.3%0.02%
0.81%
RA Capital Management, L.P.
1,184,456CL$184.4b20.6%2.33%
0.79%
Columbia Management Investment Advisers, LLC
1,150,486CL$179.1b-20.7%0.04%
0.76%
Dimensional Fund Advisors LP
1,114,340CL$173.5b0.38%0.03%
0.67%
BNY Asset Management
982,172CL$152.9b-19.5%0.03%
0.65%
Renaissance Technologies LLC
952,706CL$148.3b54.1%0.21%
0.63%
Charles Schwab Investment Management, Inc.
913,029CL$142.2b1.37%0.02%
0.62%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
903,148CL$140.6b4.71%0.04%
0.62%
Amundi Asset Management SAS
902,664CL$140.5b31.4%0.03%
0.56%
OrbiMed Advisors LLC
813,000CL$126.6b-9.76%1.77%
0.49%
Massachusetts Financial Services Company
711,184CL$110.7b29.6%0.02%